Navigation Links
IFHP Study Reveals Disparity In Medical Costs Around The Globe
Date:3/26/2013

NEW YORK, March 26, 2013 /PRNewswire/ -- The International Federation of Health Plans today released its 2012 Comparative Price Report, detailing its annual survey of medical costs per unit. Designed to showcase the variation in healthcare costs around the world, the report examines the price of medical procedures, tests, scans and treatments in 12 countries, as well as the costs of six widely-prescribed drugs. The survey data showed that the United States continues to have the highest prices of those countries surveyed for both medical procedures and drugs.

For example, the average cost for a hospital day is $429 in Argentina, $665 in South Africa and an average of $4,287 in the U.S. A diagnostic procedure such as a colonoscopy will cost from an average of $413 in Argentina to $893 in the United Kingdom and $1,185 in the United States. The survey also found that the cost of a widely prescribed drug for depression, Cymbalta, can range from $47 in the France to $176, the average cost in the U.S.

As in prior surveys, the differential between unit prices was greatest for surgical procedures. One of the highest differentials was for C-sections: The range ran from $1,541 in Argentina to an average of $15,041 in the United States.

IFHP will host a conference call and Webinar with Chief Executive Tom Sackville at 10 a.m. PDT / 1 p.m. EDT on Tues., March 26, to discuss the findings. Details for joining the conference call and Webinar follow at the end of this news release.

"With the cost and availability of healthcare being an important topic around the world, it's essential that we not only examine the disparities that exist, but also why and how certain gaps do exist," said IFHP's Sackville.

Costs examined in the study included those from Argentina, Australia, Canada, Chile, France, Germany, India, New Zealand, South Africa, Spain, Switzerland and the United States. The data for the report was gathered from IFHP member organizations in each country.  

The IFHP was founded in 1968 by a group of health fund industry leaders, and is now the leading global network of the industry, with nearly 100 member companies across 25 countries. IFHP aims to assist in the maintenance of high ethical and professional standards throughout the industry. 

For a copy of the report and more information about IFHP, please visit www.ifhp.com.

Following are details for the conference call and Webinar to discuss the report findings:WHO:Tom Sackville, CEO of IFHPWHEN: 

Tuesday, March 2610 a.m. PDT/ 1 p.m. EDTWHERE: 

Remarks and Q&A session via conference call at (866) 901-4714 (U.S. and Canadian callers)(702) 599-4277 (callers outside United States and Canada)Conference ID: 26726254See the presentation online at: 

https://www.livemeeting.com/cc/edelman/join?id=FFMMB2&role=attend&pw=T%2F%7E5dhp
Meeting ID: FFMMB2
Entry Code: T/~5dhp

First Time Users:
To save time before the meeting, check your system to make sure it is ready to use Microsoft Office Live Meeting.

Troubleshooting
Unable to join the meeting? Follow these steps:

1.

Copy this address and paste it into your web browser: https://www.livemeeting.com/cc/edelman/join 2.

Copy and paste the required information: Meeting ID: FFMMB2Entry Code: T/~5dhpLocation: https://www.livemeeting.com/cc/edelman


'/>"/>
SOURCE International Federation of Health Plans
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
3. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
4. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
5. Shingles Vaccine is Safe, According to New Study
6. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
8. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
11. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage ... unmet medical needs, today announced that it will ... development program, based on its proprietary self-delivering RNAi ... (SID) 76 th Annual Meeting.  The SID ... relevant to skin health and disease through education, ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... An April 24th article on Yahoo! Beauty discusses ... with the help of a weight loss surgery. The woman, declaring “I will not hate ... been left following her dramatic weight loss. Dr. Feiz & Associates notes that, while it ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
Breaking Medicine News(10 mins):